Inventor · disambiguated record
James W. Larrick
Also filed as: LARRICK JAMES · LARRICK JAMES W · LARRICK JAMES WILLIAM
55 granted patents·27 pending applications·923 citations·filing 1984–2024
99Inventor score
Top patents by PatentIndex Score
82 records- 0196US9198898B2Use of NK-1 receptor antagonists in pruritusTIGERCAT PHARMA INC·Filed 2014·Granted Dec 1, 2015·20 cites·19 claims
- 0295US9737508B2Use of NK-1 receptor antagonists in pruritusMENLO THERAPEUTICS INC·Filed 2016·Granted Aug 22, 2017·7 cites·31 claims
- 0395US9474741B2Use of NK-1 receptor antagonists in pruritusMENLO THERAPEUTICS INC·Filed 2016·Granted Oct 25, 2016·7 cites·22 claims
- 0495US9381188B2Use of NK-1 receptor antagonists in pruritusTIGERCAT PHARMA INC·Filed 2015·Granted Jul 5, 2016·9 cites·19 claims
- 0594US9968588B2Use of NK-1 receptor antagonists in pruritusMENLO THERAPEUTICS INC·Filed 2017·Granted May 15, 2018·5 cites·20 claims
- 0694US6444702B1Aminoadamantane derivatives as therapeutic agentsNEUROMOLECULAR INC·Filed 2000·Granted Sep 3, 2002·68 cites·25 claims
- 0793US9663782B2Methods and compositions for producing double allele knock outsLARIX BIOSCIENCE LLC·Filed 2014·Granted May 30, 2017·28 cites·18 claims
- 0893US7943143B2Chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion protein and uses thereofBRAASCH BIOTECH LLC·Filed 2010·Granted May 17, 2011·8 cites·16 claims
- 0992US10278952B2Use of NK-1 receptor antagonists in pruritusMENLO THERAPEUTICS INC·Filed 2018·Granted May 7, 2019·3 cites·32 claims
- 1092US9737507B2Use of NK-1 receptor antagonist serlopitant in pruritusMENLO THERAPEUTICS INC·Filed 2016·Granted Aug 22, 2017·8 cites·31 claims
- 1192US8906951B1Use of NK-1 receptor antagonists in pruritusTIGERCAT PHARMA INC·Filed 2013·Granted Dec 9, 2014·15 cites·9 claims
- 1292US6114149AAmplification of mixed sequence nucleic acid fragmentsGENELABS TECH INC·Filed 1991·Granted Sep 5, 2000·192 cites·17 claims
- 1391US6717012B2Antioxidant nitroxides and nitrones as therapeutic agentsNEUROMOLECULAR INC·Filed 2002·Granted Apr 6, 2004·47 cites·16 claims
- 1490US8889140B2Compositions and methods for tissue repairLEE RANDALL J·Filed 2008·Granted Nov 18, 2014·26 cites·5 claims
- 1590US6852889B2Antioxidant nitroxides and nitrones as therapeutic agentsPANORAMA RES INC·Filed 2004·Granted Feb 8, 2005·35 cites·14 claims
- 1690US6620845B2Aminoadamantane derivatives as therapeutic agentsNEUROMOLECULAR INC·Filed 2002·Granted Sep 16, 2003·38 cites·4 claims
- 1789US9974769B2Use of NK-1 receptor antagonist serlopitant in pruritusMENLO THERAPEUTICS INC·Filed 2017·Granted May 22, 2018·5 cites·32 claims
- 1889US9486439B2Use of NK-1 receptor antagonist serlopitant in pruritusMENLO THERAPEUTICS INC·Filed 2014·Granted Nov 8, 2016·7 cites·30 claims
- 1989US7722881B2Chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion protein and uses thereofBRAASCH BIOTECH LLC·Filed 2008·Granted May 25, 2010·7 cites·5 claims
- 2087US10617671B2Use of NK-1 receptor antagonist serlopitant in pruritusMENLO THERAPEUTICS INC·Filed 2019·Granted Apr 14, 2020·1 cites·10 claims
- 2186US10278953B2Use of NK-1 receptor antagonist serlopitant in pruritusMENLO THERAPEUTICS INC·Filed 2018·Granted May 7, 2019·3 cites·31 claims
- 2286US7326730B2Aminoadamantane derivatives as therapeutic agentsADAMAS PHARMACEUTICALS INC·Filed 2005·Granted Feb 5, 2008·7 cites·13 claims
- 2385US11447442B2Aminoadamantyl nitrate compounds and their use to treat CNS disordersPANORAMA RES INC·Filed 2018·Granted Sep 20, 2022·1 cites·20 claims
- 2484US8367073B2Chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion protein and uses thereofBRAASCH BIOTECH LLC·Filed 2011·Granted Feb 5, 2013·4 cites·17 claims
- 2582US10702499B2Use of NK-1 receptor antagonists in pruritusMENLO THERAPEUTICS INC·Filed 2019·Granted Jul 7, 2020·1 cites·20 claims
- 2676US11060083B2Methods and compositions for producing double allele knock outsLARIX BIOSCIENCE LLC·Filed 2017·Granted Jul 13, 2021·1 cites·19 claims
- 2776US9910038B2Cell line screening methodLARIX BIOSCIENCES LLC·Filed 2013·Granted Mar 6, 2018·2 cites·19 claims
- 2876US5843937ADNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agentsPANORAMA RES INC·Filed 1996·Granted Dec 1, 1998·46 cites·41 claims
- 2976US5001065AHuman cell line and triomas, antibodies, and transformants derived therefromCETUS CORP·Filed 1987·Granted Mar 19, 1991·44 cites·5 claims
- 3076US4624921AHuman lymphoblastold cell line and hybridomas derived therefromCETUS CORP·Filed 1984·Granted Nov 25, 1986·33 cites·8 claims
- 3175US12071392B2Aminoadamantyl nitrate compounds and their use to treat CNS disordersPANORAMA RES INC·Filed 2022·Granted Aug 27, 2024·0 cites·17 claims
- 3275US7951378B2Immunoadhesin comprising a chimeric ICAM-1 molecule produced in a plantPLANET BIOTECHNOLOGY INC·Filed 2001·Granted May 31, 2011·14 cites·49 claims
- 3375US4677070APseudomonas aeruginosa exotoxin A antibodies, their preparation and useCETUS CORP·Filed 1985·Granted Jun 30, 1987·32 cites·3 claims
- 3474US11078276B2Anti-CD79 antibodies and their usesNepenthe Bioscience LLC·Filed 2019·Granted Aug 3, 2021·1 cites·13 claims
- 3573US8425914B2Methods for enhanced somatostatin immunogenicity in the treatment of obesityHAFFER KEITH N·Filed 2009·Granted Apr 23, 2013·3 cites·2 claims
- 3669US11026920B2Use of NK-1 receptor antagonist serlopitant in pruritusVYNE THERAPEUTICS INC·Filed 2020·Granted Jun 8, 2021·0 cites·20 claims
- 3769US5618675AMethods and compositions for detecting lipopolysaccharides using CAP18 fragmentsPANORAMA RES INC·Filed 1994·Granted Apr 8, 1997·26 cites·5 claims
- 3865US5567611AMultifunctional M-CSF proteins and genes encoding thereforCETUS ONOCOLOGY CORP·Filed 1994·Granted Oct 22, 1996·23 cites·23 claims
- 3964US11161800B2Amantadine nitrate compounds for use as medicaments for the treatment of diseasesGUANGZHOU MAGPIE PHARMACEUTICALS CO LTD·Filed 2018·Granted Nov 2, 2021·0 cites·4 claims
- 4064US6291431B1Methods and compositions for the treatment and prevention of Staphylococcal infectionsPANORAMA RES·Filed 1998·Granted Sep 18, 2001·26 cites·26 claims
- 4164US6103888AMammalian cationic proteins having lipopolysaccharide binding and anti-coagulant activityPANORAMA RES INC·Filed 1999·Granted Aug 15, 2000·15 cites·1 claims
- 4264US5605826A24 kilodalton cytoplasmic protease activating DNA fragmentation in apoptosisPANORAMA RES INC·Filed 1994·Granted Feb 25, 1997·29 cites·10 claims
- 4364US2015104478A1Compositions and methods for tissue repairTRANSTARGET INC·Filed 2014·Application pending·0 cites
- 4464US2019125891A1Compositions and methods for tissue repairTRANSTARGET INC·Filed 2019·Application pending·0 cites
- 4563US2008183003A1Aminoadamantane derivatives as therapeutic agentsADAMAS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 4662US2025319127A1Bispecific antibodiesHUANG MANLEY·Filed 2022·Application pending·0 cites
- 4762US2025042970A1B cell activating factor (baff)-a proliferation inducing ligand (april) dual inhibitorsAURINIA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4861US10214478B2Amantadine nitrate compounds with neural protective effect, and preparation and medical use thereofGUANGZHOU MAGPIE PHARMACEUTICALS CO LTD·Filed 2016·Granted Feb 26, 2019·0 cites·6 claims
- 4960US8101199B2Des-methyl-tocopherol therapy for restenosis preventionLARRICK JAMES W·Filed 2004·Granted Jan 24, 2012·3 cites·19 claims
- 5058US10654925B2Anti-marinobufagenin antibodies and uses thereofCTS Biopharma LLC·Filed 2019·Granted May 19, 2020·0 cites·17 claims
Showing the top 50 of 82 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when James W. Larrick files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →